Results 241 to 250 of about 55,639 (278)
Some of the next articles are maybe not open access.

Pediatric Epistaxis

The Laryngoscope, 2006
AbstractObjectives/Hypothesis: Otolaryngologists are frequently consulted for the evaluation and treatment of pediatric epistaxis. There is a lack of consensus as to the optimal approach to this problem. This study evaluated an approach used to evaluate and treat patients referred on an outpatient basis.Study Design: Retrospective study.Methods: Charts
John F, Damrose, John, Maddalozzo
openaire   +2 more sources

Epistaxis Risk Associated with Intranasal Corticosteroid Sprays: A Systematic Review and Meta-analysis

Otolaryngology Head & Neck Surgery, 2019
Objective Intranasal corticosteroids (INCSs) are widely utilized for the treatment of allergic rhinitis. Epistaxis is a known adverse effect of INCSs, but it is not known if the risk of epistaxis differs among INCSs.
Eric L Wu   +5 more
semanticscholar   +1 more source

Role of age and anticoagulants in recurrent idiopathic epistaxis.

Acta Otorrinolaringológica Española, 2020
OBJECTIVE Epistaxis is one of the commonest causes of attendance of Otolaryngology emergency rooms. Given its incidence, potential severity and high recurrence rate, a systematic and careful management is mandatory.
Patricia S Gomes   +4 more
semanticscholar   +1 more source

Etiology, Management, and Outcome of Pediatric Epistaxis

Pediatric emergency care, 2019
Objective Epistaxis in children is one of the most common causes for seeking professional medical help. Patients may be treated by several disciplines with various approaches to pediatric epistaxis.
T. Send   +7 more
semanticscholar   +1 more source

Lethal Epistaxis

Journal of Forensic Sciences, 2016
AbstractEpistaxis or nosebleed refers to bleeding from the nostrils, nasal cavity, or nasopharynx. Occasional cases may present with torrential lethal hemorrhage. Three cases are reported to demonstrate particular features: Case 1: A 51‐year‐old woman with lethal epistaxis with no obvious bleeding source; Case 2: A 77‐year‐old man with treated ...
openaire   +3 more sources

Comparative Effectiveness of Topically Administered Tranexamic Acid Versus Topical Oxymetazoline Spray for Achieving Hemostasis in Epistaxis.

Journal of Emergency Medicine, 2019
BACKGROUND The use of tranexamic acid (TXA) has recently gained popularity as a treatment modality for epistaxis in the emergency department. Previous studies have compared topical TXA to nasal packing. However, topical TXA has not yet been compared with
K. Whitworth   +3 more
semanticscholar   +1 more source

Teachers’ awareness regarding first-aid management and control of epistaxis inside schools in Riyadh region, Saudi Arabia

International Journal of Medicine in Developing Countries, 2019
Background: Epistaxis is one of the most common otorhinolaryngology emergencies occurring in pediatric population due to school injuries and traumas, predisposing them to require basic yet important first-aid management. This study was done to assess the
Yassir Al-kubaisy   +6 more
semanticscholar   +1 more source

Endovascular Embolization in the Treatment of Epistaxis

Otolaryngology Head & Neck Surgery, 2019
Objective The cost-effectiveness of endovascular embolization (EE) for intractable epistaxis has been questioned, especially as endoscopic surgical techniques have become standard of care at many institutions.
Phillip Huyett   +3 more
semanticscholar   +1 more source

Sclerotherapy and Topical Nasal Propranolol: An Effective and Safe Therapy for HHT‐Epistaxis

The Laryngoscope, 2019
Epistaxis is the most frequent clinical manifestation of hereditary hemorrhagic telangiectasia (HHT). Several topical, systemic, and surgical treatments have been tried, but none have been completely effective. The aim of the present study is to evaluate
S. Esteban-Casado   +7 more
semanticscholar   +1 more source

Bevacizumab as Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Literature Review

Annals of Otology, Rhinology and Laryngology, 2019
Background: Severe, recurring epistaxis is the most common symptom of hereditary hemorrhagic telangiectasias (HHT). Current treatment modalities range from noninvasive treatments that frequently fail to achieve even short-term control to surgeries and ...
Sameer D. Kini   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy